Contract Pharma

Targeted Modalities Set Elevated Standards for Precision

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...
Nasdaq

Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH

Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
Seeking Alpha

AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

NORTH CHICAGO, Ill., Dec. 2, 2025 /PRNewswire/ -- AbbVie today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research ...
CU Boulder News & Events

Multi-modal Speech Transformer Decoders: When Do Multiple Modalities Improve Accuracy?

Multi-modal Speech Transformer Decoders: When Do Multiple Modalities Improve Accuracy? Authors: Guan, Y., Trinh, V.A., Voleti, V., and Whitehill, J.
Seeking Alpha

Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH

Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...